SlideShare a Scribd company logo
1 of 14
Scientific Publications Strategy: Managing Reputation, Clinical Trial Results and Commercial Relevance  Best Practices, LLC Benchmarking Report
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Table of Contents
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Table of Contents
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Table of Contents
Project Methodology and Study Objectives ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Global publications are under the microscope with calls for improved transparency and data disclosure. Due to this, global publications leaders find themselves in a balancing act—needing to ensure both scientific credibility and commercial viability.   This study investigates the impact of industry and corporate transparency policies on the operation of publication function at Pharma/Biotech Companies.
Summary of Key Insights
Key Findings (Samples) ,[object Object],[object Object],The following key findings and insights emerged from the field surveys, direct interviews and study verbatim.
Universe of Learning
List of Participating Companies The benchmark class includes 17 participants from 16 companies across the pharmaceutical, biotech and medical device industries.  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],2011 2009 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Range of Career Levels Lend Insight ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Research participants’ roles ranged from senior leaders to managers of medical affairs, Publications and Communications.  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],2011 2009 2011
Respondents Serve Various Therapeutic Areas ,[object Object],N2011=17 ,[object Object],[object Object],Please specify the therapeutic area(s) you serve in the scientific publication department. (Check all that apply.)
Six 6 FTEs Work in Scientific Publications, on Average ,[object Object],How many FTEs work within your scientific Publications Function? N2011=13
Vice President Oversees Publication Function ,[object Object],N2011=17 ,[object Object],[object Object],Who oversees your Publications function?
About Best Practices, LLC Best Practices, LLC is a research and consulting firm that conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.  Best Practices, LLC 6350 Quadrangle Drive, Suite 200, Chapel Hill, NC 27517 919-403-0251 [email_address] www.best-in-class.com

More Related Content

What's hot

Real World Late Phase The right approach for the right question
Real World Late Phase The right approach for the right questionReal World Late Phase The right approach for the right question
Real World Late Phase The right approach for the right question
Satish Kumar
 
Measures of performance and clinical outcome
Measures of performance and clinical outcomeMeasures of performance and clinical outcome
Measures of performance and clinical outcome
Mohamed Mosaad Hasan
 
Avoca Quality Consortium Meeting Topics Day 2, May 7
Avoca Quality Consortium Meeting Topics Day 2, May 7Avoca Quality Consortium Meeting Topics Day 2, May 7
Avoca Quality Consortium Meeting Topics Day 2, May 7
The Avoca Group
 
Health Informatics Journal - Balanced Scorecard
Health Informatics Journal - Balanced ScorecardHealth Informatics Journal - Balanced Scorecard
Health Informatics Journal - Balanced Scorecard
Julius Veracion
 

What's hot (20)

Health Economics Outcomes Research Pharmaceutical Brand Management In Managed...
Health Economics Outcomes Research Pharmaceutical Brand Management In Managed...Health Economics Outcomes Research Pharmaceutical Brand Management In Managed...
Health Economics Outcomes Research Pharmaceutical Brand Management In Managed...
 
Real World Late Phase The right approach for the right question
Real World Late Phase The right approach for the right questionReal World Late Phase The right approach for the right question
Real World Late Phase The right approach for the right question
 
Generating Evidence to Drive Patient Access
Generating Evidence to Drive Patient AccessGenerating Evidence to Drive Patient Access
Generating Evidence to Drive Patient Access
 
Developing Drugs in the New Era of Personalized Medicines
Developing Drugs in the New Era of Personalized Medicines Developing Drugs in the New Era of Personalized Medicines
Developing Drugs in the New Era of Personalized Medicines
 
Fundamentals of Health Economics and Outcomes Research (HEOR)
Fundamentals of Health Economics and Outcomes Research (HEOR)Fundamentals of Health Economics and Outcomes Research (HEOR)
Fundamentals of Health Economics and Outcomes Research (HEOR)
 
Measures of performance and clinical outcome
Measures of performance and clinical outcomeMeasures of performance and clinical outcome
Measures of performance and clinical outcome
 
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIESOPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
 
Avoca Quality Consortium Meeting Topics Day 2, May 7
Avoca Quality Consortium Meeting Topics Day 2, May 7Avoca Quality Consortium Meeting Topics Day 2, May 7
Avoca Quality Consortium Meeting Topics Day 2, May 7
 
Emerging Strategies in Drug Innovation
Emerging Strategies in Drug InnovationEmerging Strategies in Drug Innovation
Emerging Strategies in Drug Innovation
 
Rising Importance of Health Economics & Outcomes Research
Rising Importance of Health Economics & Outcomes ResearchRising Importance of Health Economics & Outcomes Research
Rising Importance of Health Economics & Outcomes Research
 
OHE RWE Poster - HTAi Tokyo May 2016
OHE RWE Poster - HTAi Tokyo May 2016OHE RWE Poster - HTAi Tokyo May 2016
OHE RWE Poster - HTAi Tokyo May 2016
 
Planning, monitoring & evaluation of health care program
Planning, monitoring & evaluation of health care programPlanning, monitoring & evaluation of health care program
Planning, monitoring & evaluation of health care program
 
Health Informatics Journal - Balanced Scorecard
Health Informatics Journal - Balanced ScorecardHealth Informatics Journal - Balanced Scorecard
Health Informatics Journal - Balanced Scorecard
 
Hm306 week 8
Hm306 week 8Hm306 week 8
Hm306 week 8
 
TransCelerate Overview - Interpretation of Pharmacovigilance Regulations Init...
TransCelerate Overview - Interpretation of Pharmacovigilance Regulations Init...TransCelerate Overview - Interpretation of Pharmacovigilance Regulations Init...
TransCelerate Overview - Interpretation of Pharmacovigilance Regulations Init...
 
Operational research in Public Health in India
Operational research in Public Health in IndiaOperational research in Public Health in India
Operational research in Public Health in India
 
Key Issues on the Economics of Precision Medicine
Key Issues on the Economics of Precision MedicineKey Issues on the Economics of Precision Medicine
Key Issues on the Economics of Precision Medicine
 
EIU Value Challenge
EIU Value ChallengeEIU Value Challenge
EIU Value Challenge
 
Understanding Different Stakeholder Requirements Throughout Commercialization
Understanding Different Stakeholder Requirements Throughout CommercializationUnderstanding Different Stakeholder Requirements Throughout Commercialization
Understanding Different Stakeholder Requirements Throughout Commercialization
 
Four Disruptive Strategies for Removing Drug Discovery Bottlenecks
Four Disruptive Strategies for Removing Drug Discovery BottlenecksFour Disruptive Strategies for Removing Drug Discovery Bottlenecks
Four Disruptive Strategies for Removing Drug Discovery Bottlenecks
 

Similar to Scientific Publication Strategy

Success Factors and Failure Points in Metabolic Product Launches
Success Factors and Failure Points in Metabolic Product LaunchesSuccess Factors and Failure Points in Metabolic Product Launches
Success Factors and Failure Points in Metabolic Product Launches
Best Practices, LLC
 
Roles, Resources, and Managemet of Medical Science Liaisons
Roles, Resources, and Managemet of Medical Science LiaisonsRoles, Resources, and Managemet of Medical Science Liaisons
Roles, Resources, and Managemet of Medical Science Liaisons
Best Practices, LLC
 
Pharmmaceutical Publication Planning and Management Agenda
Pharmmaceutical Publication Planning and Management AgendaPharmmaceutical Publication Planning and Management Agenda
Pharmmaceutical Publication Planning and Management Agenda
Svetlana Pidasheva, PhD, CMPP
 
Medical Affairs Resources, Structures, & Trends Report Summary
Medical Affairs Resources, Structures, & Trends Report SummaryMedical Affairs Resources, Structures, & Trends Report Summary
Medical Affairs Resources, Structures, & Trends Report Summary
Best Practices, LLC
 
Scientific Publications Strategy- Managing Reputation, Clinical Trial Results...
Scientific Publications Strategy- Managing Reputation, Clinical Trial Results...Scientific Publications Strategy- Managing Reputation, Clinical Trial Results...
Scientific Publications Strategy- Managing Reputation, Clinical Trial Results...
Best Practices
 
Success Factors and Failure Points in Metabolic Product Launches Report Summary
Success Factors and Failure Points in Metabolic Product Launches Report SummarySuccess Factors and Failure Points in Metabolic Product Launches Report Summary
Success Factors and Failure Points in Metabolic Product Launches Report Summary
Best Practices
 

Similar to Scientific Publication Strategy (20)

Disease Awareness Program Excellence: Structure, Timing, Activities & Investm...
Disease Awareness Program Excellence: Structure, Timing, Activities & Investm...Disease Awareness Program Excellence: Structure, Timing, Activities & Investm...
Disease Awareness Program Excellence: Structure, Timing, Activities & Investm...
 
Strategies to Increase Medical Affairs' Role in Health Outcomes Data Generati...
Strategies to Increase Medical Affairs' Role in Health Outcomes Data Generati...Strategies to Increase Medical Affairs' Role in Health Outcomes Data Generati...
Strategies to Increase Medical Affairs' Role in Health Outcomes Data Generati...
 
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
 
Success Factors and Failure Points in Metabolic Product Launches
Success Factors and Failure Points in Metabolic Product LaunchesSuccess Factors and Failure Points in Metabolic Product Launches
Success Factors and Failure Points in Metabolic Product Launches
 
Best-in-Class Strategies to Develop Effective Medical Information Groups
Best-in-Class Strategies to Develop Effective Medical Information GroupsBest-in-Class Strategies to Develop Effective Medical Information Groups
Best-in-Class Strategies to Develop Effective Medical Information Groups
 
Drive Growth and Profitability Through Strategic Pharmaceutical New Product P...
Drive Growth and Profitability Through Strategic Pharmaceutical New Product P...Drive Growth and Profitability Through Strategic Pharmaceutical New Product P...
Drive Growth and Profitability Through Strategic Pharmaceutical New Product P...
 
Drive Growth and Profitability Through Strategic Pharmaceutical New Product P...
Drive Growth and Profitability Through Strategic Pharmaceutical New Product P...Drive Growth and Profitability Through Strategic Pharmaceutical New Product P...
Drive Growth and Profitability Through Strategic Pharmaceutical New Product P...
 
Roles, Resources, and Managemet of Medical Science Liaisons
Roles, Resources, and Managemet of Medical Science LiaisonsRoles, Resources, and Managemet of Medical Science Liaisons
Roles, Resources, and Managemet of Medical Science Liaisons
 
Developing High-Impact Communication Forms to Brief Senior Leaders: Optimizin...
Developing High-Impact Communication Forms to Brief Senior Leaders: Optimizin...Developing High-Impact Communication Forms to Brief Senior Leaders: Optimizin...
Developing High-Impact Communication Forms to Brief Senior Leaders: Optimizin...
 
Pharmmaceutical Publication Planning and Management Agenda
Pharmmaceutical Publication Planning and Management AgendaPharmmaceutical Publication Planning and Management Agenda
Pharmmaceutical Publication Planning and Management Agenda
 
Medical Science Liaison Webinarv 2009
Medical Science Liaison  Webinarv  2009Medical Science Liaison  Webinarv  2009
Medical Science Liaison Webinarv 2009
 
Models & Trends in REMS Program Success
Models & Trends in REMS Program SuccessModels & Trends in REMS Program Success
Models & Trends in REMS Program Success
 
New Product Planning in the Pharmaceutical Industry
New Product Planning in the Pharmaceutical IndustryNew Product Planning in the Pharmaceutical Industry
New Product Planning in the Pharmaceutical Industry
 
Disseminate Clinical Data Early to Support Payer Coverage Decisions
Disseminate Clinical Data Early to Support Payer Coverage DecisionsDisseminate Clinical Data Early to Support Payer Coverage Decisions
Disseminate Clinical Data Early to Support Payer Coverage Decisions
 
Medical Affairs Resources, Structures, & Trends Report Summary
Medical Affairs Resources, Structures, & Trends Report SummaryMedical Affairs Resources, Structures, & Trends Report Summary
Medical Affairs Resources, Structures, & Trends Report Summary
 
Fip ed rdes 2017 final
Fip ed rdes 2017 finalFip ed rdes 2017 final
Fip ed rdes 2017 final
 
Fip ed rdes 2017 final
Fip ed rdes 2017 finalFip ed rdes 2017 final
Fip ed rdes 2017 final
 
Scientific Publications Strategy- Managing Reputation, Clinical Trial Results...
Scientific Publications Strategy- Managing Reputation, Clinical Trial Results...Scientific Publications Strategy- Managing Reputation, Clinical Trial Results...
Scientific Publications Strategy- Managing Reputation, Clinical Trial Results...
 
Benchmarking Professional Medical Education Excellence Structures
Benchmarking Professional Medical Education Excellence StructuresBenchmarking Professional Medical Education Excellence Structures
Benchmarking Professional Medical Education Excellence Structures
 
Success Factors and Failure Points in Metabolic Product Launches Report Summary
Success Factors and Failure Points in Metabolic Product Launches Report SummarySuccess Factors and Failure Points in Metabolic Product Launches Report Summary
Success Factors and Failure Points in Metabolic Product Launches Report Summary
 

More from Best Practices, LLC

Product Launch Failure & Success Study
Product Launch Failure & Success StudyProduct Launch Failure & Success Study
Product Launch Failure & Success Study
Best Practices, LLC
 
New Product Launch Spend Report Summary
New Product Launch Spend Report SummaryNew Product Launch Spend Report Summary
New Product Launch Spend Report Summary
Best Practices, LLC
 
Educating KOLs, Physicians, Patients, and Payers to support successful produc...
Educating KOLs, Physicians, Patients, and Payers to support successful produc...Educating KOLs, Physicians, Patients, and Payers to support successful produc...
Educating KOLs, Physicians, Patients, and Payers to support successful produc...
Best Practices, LLC
 
Resource Benchmarks for U.S. Pharmaceutical Managed Care Operations
Resource Benchmarks for U.S. Pharmaceutical Managed Care OperationsResource Benchmarks for U.S. Pharmaceutical Managed Care Operations
Resource Benchmarks for U.S. Pharmaceutical Managed Care Operations
Best Practices, LLC
 
Oncology Global Strategic Marketing
Oncology Global Strategic MarketingOncology Global Strategic Marketing
Oncology Global Strategic Marketing
Best Practices, LLC
 
Medical Science Liaison Services Report Summary
Medical Science Liaison Services Report SummaryMedical Science Liaison Services Report Summary
Medical Science Liaison Services Report Summary
Best Practices, LLC
 
New Product Launch Spend Report Summary
New Product Launch Spend Report SummaryNew Product Launch Spend Report Summary
New Product Launch Spend Report Summary
Best Practices, LLC
 

More from Best Practices, LLC (10)

Communications Excellence
Communications ExcellenceCommunications Excellence
Communications Excellence
 
Product Launch Failure & Success Study
Product Launch Failure & Success StudyProduct Launch Failure & Success Study
Product Launch Failure & Success Study
 
Corporate Affairs Excellence
Corporate Affairs ExcellenceCorporate Affairs Excellence
Corporate Affairs Excellence
 
New Product Launch Spend Report Summary
New Product Launch Spend Report SummaryNew Product Launch Spend Report Summary
New Product Launch Spend Report Summary
 
Educating KOLs, Physicians, Patients, and Payers to support successful produc...
Educating KOLs, Physicians, Patients, and Payers to support successful produc...Educating KOLs, Physicians, Patients, and Payers to support successful produc...
Educating KOLs, Physicians, Patients, and Payers to support successful produc...
 
CI Guidelines Summary
CI Guidelines SummaryCI Guidelines Summary
CI Guidelines Summary
 
Resource Benchmarks for U.S. Pharmaceutical Managed Care Operations
Resource Benchmarks for U.S. Pharmaceutical Managed Care OperationsResource Benchmarks for U.S. Pharmaceutical Managed Care Operations
Resource Benchmarks for U.S. Pharmaceutical Managed Care Operations
 
Oncology Global Strategic Marketing
Oncology Global Strategic MarketingOncology Global Strategic Marketing
Oncology Global Strategic Marketing
 
Medical Science Liaison Services Report Summary
Medical Science Liaison Services Report SummaryMedical Science Liaison Services Report Summary
Medical Science Liaison Services Report Summary
 
New Product Launch Spend Report Summary
New Product Launch Spend Report SummaryNew Product Launch Spend Report Summary
New Product Launch Spend Report Summary
 

Scientific Publication Strategy

  • 1. Scientific Publications Strategy: Managing Reputation, Clinical Trial Results and Commercial Relevance Best Practices, LLC Benchmarking Report
  • 2.
  • 3.
  • 4.
  • 5.
  • 6. Summary of Key Insights
  • 7.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14. About Best Practices, LLC Best Practices, LLC is a research and consulting firm that conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC 6350 Quadrangle Drive, Suite 200, Chapel Hill, NC 27517 919-403-0251 [email_address] www.best-in-class.com